{"id":"coronovac","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or erythema"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Myalgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"CoronoVAC is an inactivated or protein-based vaccine in development to prevent COVID-19 infection by stimulating both humoral and cellular immune responses against SARS-CoV-2 antigens. The vaccine aims to generate neutralizing antibodies and T-cell responses to protect against infection and severe disease. As a Phase 2 candidate, it is being evaluated for safety, tolerability, and immunogenicity in human subjects.","oneSentence":"CoronoVAC is a COVID-19 vaccine candidate designed to elicit immune responses against SARS-CoV-2.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:28:57.789Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention"}]},"trialDetails":[{"nctId":"NCT04765215","phase":"","title":"Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.","status":"UNKNOWN","sponsor":"Asoc. Prof. Erdoğan Selçuk Şeber","startDate":"2021-03-31","conditions":"Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy","enrollment":291},{"nctId":"NCT04751721","phase":"NA","title":"Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines","status":"UNKNOWN","sponsor":"Izmir Bakircay University","startDate":"2021-02","conditions":"Covid-19 Vaccine","enrollment":20},{"nctId":"NCT04751695","phase":"NA","title":"Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines","status":"UNKNOWN","sponsor":"Izmir Bakircay University","startDate":"2021-02","conditions":"Covid-19 Vaccine","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CoronoVAC","genericName":"CoronoVAC","companyName":"Asoc. Prof. Erdoğan Selçuk Şeber","companyId":"asoc-prof-erdo-an-sel-uk-eber","modality":"Biologic","firstApprovalDate":"","aiSummary":"CoronoVAC is a COVID-19 vaccine candidate designed to elicit immune responses against SARS-CoV-2. Used for COVID-19 prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}